The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Chemokines: immunology's high impact factors
Mackay, C. R. (2001) · Nature Immunology · doi:10.1038/84298 · Cited by 845
(2000) · PubMed · Cited by 706
The chemokine and chemokine receptor superfamilies and their molecular evolution.
Zlotnik, A., Yoshie, O., & Nomiyama, H. (2006) · Genome biology · doi:10.1186/gb-2006-7-12-243 · Cited by 604
Cancer related inflammation: the macrophage connection
Sica, A., Allavena, P., & Mantovani, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.028 · Cited by 601
Role of chemokines in tumor growth
Raman, D., Baugher, P. J., Thu, Y. M., & Richmond, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.05.013 · Cited by 578
Tumor-Associated Macrophages Press the Angiogenic Switch in Breast Cancer
Lin, E. Y., & Pollard, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0912 · Cited by 463
Dwyer, R. M., Potter-Beirne, S. M., Harrington, K. A., Lowery, A. J., Hennessy, E., Murphy, J. M., Barry, F. P., O'Brien, T., & Kerin, M. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0731 · Cited by 431
Cancer CXC chemokine networks and tumour angiogenesis
Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B., Keane, M. P., & Belperio, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.006 · Cited by 410
Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 371
Self-citationChemokine/Chemokine Receptor Nomenclature
(2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760624305 · Cited by 353
Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., & Ben‐Baruch, A. (1999) · PubMed · Cited by 350
Self-citationOestrogen receptor negative breast cancers exhibit high cytokine content
Chavey, C., Bibeau, F., Gourgou-Bourgade, S., Burlinchon, S., Boissière, F., Laune, D., Roques, S., & Lazennec, G. (2007) · Breast Cancer Research · doi:10.1186/bcr1648 · Cited by 349
BENBARUCH, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 335
Self-citationInduction of inflammatory angiogenesis by monocyte chemoattractant protein-1
Goede, V., Brogelli, L., Ziche, M., & Augustin, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f · Cited by 319
CCL2 (monocyte chemoattractant protein-1) and cancer
Conti, I., & Rollins, B. J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.009 · Cited by 314
Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment
Celis, J. E., Gromov, P., Cabezón, T., Moreira, J. M. A., Ambartsumian, N., Sandelin, K., Rank, F., & Gromova, I. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400009-mcp200 · Cited by 305
Gazzaniga, S., Bravo, A. I., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., & Wainstok, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700827 · Cited by 302
Ben-Baruch, A. (2002) · Breast Cancer Research · doi:10.1186/bcr554 · Cited by 300
Self-citationSaji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., & Toi, M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k · Cited by 288
Weber, K. S. C., Nelson, P. J., Gröne, H.-J., & Weber, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2085 · Cited by 279
The multifaceted roles of chemokines in malignancy
Ben-Baruch, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9003-5 · Cited by 259
Self-citationA chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 259
Molecular Profiling of Inflammatory Breast Cancer
Bièche, I., Lerebours, F., Tozlu, S., Espie, M., Marty, M., & Lidereau, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0306 · Cited by 245
Niwa, Y., Akamatsu, H., Niwa, H., Sumi, H., Ozaki, Y., & Abe, A. (2001) · PubMed · Cited by 245
DuPre´, S. A., Redelman, D., & Hunter, K. W. (2007) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00539.x · Cited by 220
Madhusudan, S., Foster, M., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0730 · Cited by 205
Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α
Robinson, S. C., Scott, K. A., & Balkwill, F. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2<404::aid-immu404>3.0.co;2-x · Cited by 201
Macrophages promote angiogenesis in human breast tumour spheroids in vivo
Bingle, L., Lewis, C. E., Corke, K. P., Reed, M. W. R., & Brown, N. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602901 · Cited by 189
Khodarev, N. N., Yu, J., Labay, E., Darga, T., Brown, C. K., Mauceri, H. J., Yassari, R., Gupta, N., & Weichselbaum, R. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00281 · Cited by 181
CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases
Craig, M. J., & Loberg, R. D. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9027-x · Cited by 165
Natural Killer Cells Produce T Cell–Recruiting Chemokines in Response to Antibody-Coated Tumor Cells
Roda, J. M., Parihar, R., Magro, C., Nuovo, G. J., Tridandapani, S., & Carson, W. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2429 · Cited by 165
Involvement of Chemokine Receptors in Organ-Specific Metastasis
Zlotnik, A. (2006) · Contributions to Microbiology · doi:10.1159/000092973 · Cited by 159
Chemokine Regulation of Normal and Pathologic Immune Responses
Christopherson, K. W., & Hromas, R. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-388 · Cited by 156
Yaal‐Hahoshen, N., Shina, S., Leider–Trejo, L., Barnea, I., Shabtai, E. L., Azenshtein, E., Greenberg, I., Keydar, I., & Ben‐Baruch, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0074 · Cited by 151
Self-citationWang, J., Ou, Z.-L., Hou, Y.-F., Luo, J.-M., Shen, Z.-Z., Ding, J., & Shao, Z.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209703 · Cited by 147
Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue
Silzle, T., Kreutz, M. P., Dobler, M. A., Brockhoff, G., Knuechel, R., & Kunz‐Schughart, L. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323057 · Cited by 145
CCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner
Mañes, S., Mira, E., Colomer, R., Montero, S., Real, L. M., Gómez‐Moutón, C., Jiménez-Baranda, S., Garzón, A., Lacalle, R. A., Harshman, K., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030580 · Cited by 140
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
Valković, T., Lučin, K., Krstulja, M., Dobi-Babić, R., & Jonjić, N. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80057-5 · Cited by 137
Yamashiro, S., Takeya, M., Nishi, T., Kuratsu, J. I., Yoshimura, T., Ushio, Y., & Takahashi, K. (1994) · PubMed Central · Cited by 132
Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer
Lebrecht, A., Grimm, C., Lantzsch, T., Ludwig, E., Hefler, L., Ulbrich, E. J., & Koelbl, H. (2004) · Tumor Biology · doi:10.1159/000077718 · Cited by 131
Kuroda, T., Kitadai, Y., Tanaka, S., Yang, X., Mukaida, N., Yoshihara, M., & Chayama, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0798 · Cited by 129
Novel c‐MYC target genes mediate differential effects on cell proliferation and migration
Cappellen, D., Schlange, T., Bauer, M., Maurer, F., & Hynes, N. E. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400849 · Cited by 125
Significant involvement of CCR2–64I and CXCL12–3a in the development of sporadic breast cancer
Zafiropoulos, A., Crikas, N., Passam, A. M., & Spandidos, D. A. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013649 · Cited by 114
Cytokine Comparisons Between Women With Breast Cancer and Women With a Negative Breast Biopsy
Lyon, D., McCain, N. L., Walter, J. M., & Schubert, C. M. (2008) · Nursing Research · doi:10.1097/01.nnr.0000280655.58266.6c · Cited by 112
Zhu, J., Jia, X., Xiao, G., Kang, Y., Partridge, N. C., & Qin, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705064200 · Cited by 109
Nam, J., Kang, M., Suchar, A. M., Shimamura, T., Kohn, E. A., Michalowska, A. M., Jordan, V. C., Hirohashi, S., & Wakefield, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0825 · Cited by 108
Yamada, M., Kim, S., Egashira, K., Takeya, M., Ikeda, T., Mimura, O., & Iwao, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000096208.80992.63 · Cited by 105
Metastatic breast cancer induces an osteoblast inflammatory response
Kinder, M., Chislock, E. M., Bussard, K. M., Shuman, L. A., & Mastro, A. M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.021 · Cited by 102
HIV and the CCR5-Δ32 resistance allele
de Silva, E., & Stumpf, M. P. H. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.09.040 · Cited by 94
Azenshtein, E., Meshel, T., Shina, S., Barak, N., Keydar, I., & Ben‐Baruch, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.024 · Cited by 92
Self-citationA dual role for tumor-derived chemokine RANTES (CCL5)
Adler, E. P., Lemken, C. A., Katchen, N. S., & Kurt, R. A. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.09.013 · Cited by 89
Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice
Koga, M., Kai, H., Egami, K., Murohara, T., Ikeda, A., Yasuoka, S., Egashira, K., Matsuishi, T., Kai, M., Kataoka, Y., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.182 · Cited by 88
A role for chemokine receptor transactivation in growth factor signaling
Mira, E., Lacalle, R. A., González, M. A., Gómez‐Moutón, C., Abad, J. L., Bernad, A., Martínez‐A, C., & Mañes, S. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve027 · Cited by 86
Transactivation of MCP‐1/CCL2 by β‐catenin/TCF‐4 in human breast cancer cells
Mestdagt, M., Polette, M., Butticè, G., Noël, A., Ueda, A., Foidart, J., & Gilles, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21291 · Cited by 85
Dehqanzada, Z. A., Storrer, C. E., Hueman, M. T., Foley, R. J., Harris, K. A., Jama, Y. H., Shriver, C. D., Ponniah, S., & Peoples, G. E. (2007) · Oncology Reports · doi:10.3892/or.17.3.687 · Cited by 82
Importance of serum IL-18 and RANTES as markers for breast carcinoma progression.
Eissa, S. A. L., Zaki, S. A., EL‐Maghraby, S. M., & Kadry, D. Y. (2005) · PubMed · Cited by 75
Fritz, E. A., Glant, T. T., Vermes, C., Jacobs, J. J., & Roebuck, K. A. (2002) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(01)00154-1 · Cited by 74
Inadera, H., Sekiya, T., Yoshimura, T., & Matsushima, K. (2000) · Endocrinology · doi:10.1210/endo.141.1.7233 · Cited by 64
Varney, M. L., Olsen, K. J., Mosley, R. L., Bucana, C. D., Talmadge, J. E., & Singh, R. K. (2002) · PubMed · Cited by 63
Ghilardi, G., Biondi, M. L., Torre, A. L., Battaglioli, L., & Scorza, R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041657 · Cited by 63
Neumark, E., Sagi‐Assif, O., Shalmon, B., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11337 · Cited by 61
Inhibition of metastasis by inhibition of tumor-derived CCL5
Stormes, K. A., Lemken, C. A., Lepre, J. V., Marinucci, M., & Kurt, R. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-5328-3 · Cited by 55
Chemokine Receptor Desensitization in Tumor-Bearing Mice
Kurt, R. A., Baher, A., Wisner, K. P., Tackitt, S., & Urba, W. J. (2001) · Cellular Immunology · doi:10.1006/cimm.2000.1754 · Cited by 55
Ali, S., Kaur, J., & Patel, K. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64542-7 · Cited by 50
The Inhibition of Synthesis of a β-Chemokine, Monocyte Chemotactic Protein-1 (MCP-1) by Progesterone
KELLY, R. W., Carr, G. G., & Riley, S. C. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7502 · Cited by 50
Chemokine-Induced Secretion of Gelatinase B in Primary Human Monocytes
Klier, C. M., Nelson, E. L., Cohen, C. D., Horuk, R., Schlöndorff, D., & Nelson, P. J. (2001) · Biological Chemistry · doi:10.1515/bc.2001.173 · Cited by 49
Impact of tumor-derived CCL2 on T cell effector function
Vitiello, P. F., Shainheit, M. G., Allison, E. M., Adler, E. P., & Kurt, R. A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.12.009 · Cited by 46
Comes, A., Carlo, E. D., Musiani, P., Rosso, O., Meazza, R., Chiodoni, C., Colombo, M. P., & Ferrini, S. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1914::aid-immu1914>3.0.co;2-p · Cited by 45
Dehqanzada, Z. A., Storrer, C. E., Hueman, M. T., Foley, R. J., Harris, K. A., Jama, Y. H., Kao, T.-C., Shriver, C. D., Ponniah, S., & Peoples, G. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1425 · Cited by 45
Carlo, E. D., Cappello, P., Sorrentino, C., D’Antuono, T., Pellicciotta, A., Giovarelli, M., Forni, G., Musiani, P., & Triebel, F. (2004) · The Journal of Pathology · doi:10.1002/path.1679 · Cited by 44
Prest, S. J., Rees, R. C., Murdoch, C., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006657109866 · Cited by 42
Neumark, E., Anavi, R., Witz, I. P., & Ben‐Baruch, A. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00043-7 · Cited by 39
Self-citationLopez, M. V., Adris, S., Bravo, A., Chernajovsky, Y., & Podhajcer, O. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5885 · Cited by 37
Değerli, N., Yılmaz, E., & Bardakçi, F. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.11.001 · Cited by 32
ABUNDANT EXPRESSION OF CHEMOKINES IN MALIGNANT AND INFECTIVE HUMAN LYMPHADENOPATHIES
Tedla, N. T., Palladinetti, P., Wakefield, D., & Lloyd, A. R. (1999) · Cytokine · doi:10.1006/cyto.1998.0439 · Cited by 31
The expression of CCL2 by T lymphocytes of mammary tumor bearers: Role of tumor-derived factors
Owen, J. L., Lopez, D. M., Grosso, J. F., Guthrie, K. M., Herbert, L. M., Torroella‐Kouri, M., & Iragavarapu‐Charyulu, V. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.08.032 · Cited by 30
Valković, T., Čupić, D. F., Štifter, S., Matušan‐Ilijaš, K., Hasan, M., Dobrila, F., & Jonjić, N. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0667-3 · Cited by 29
Tumor-derived CCL5 does not contribute to breast cancer progression
Jayasinghe, M. M., Golden, J. M., Nair, P., O’Donnell, C., Werner, M. T., & Kurt, R. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9802-6 · Cited by 27
Seeger, H., Wallwiener, D. R., & Mueck, A. O. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.042 · Cited by 27
Manjili, M. H., Arnouk, H., Knutson, K. L., Kmieciak, M., Disis, M. L., Subjeck, J. R., & Kazim, A. L. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9044-4 · Cited by 26
Aronica, S. M., Fanti, P., Kaminskaya, K., Gibbs, K., Raiber, L., Nazareth, M. R., Bucelli, R. C., Mineo, M., Grzybek, K., Kumin, M., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000019961.59306.f6 · Cited by 23
Sun, X. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i15.2283 · Cited by 21
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas
Neumark, E., Cohn, M. A., Lukanidin, E. M., Witz, I. P., & Ben‐Baruch, A. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00026-3 · Cited by 20
Self-citationCarlo, E. D., Modesti, A., Coletti, A., Colombo, M. P., Giovarelli, M., Forni, G., Diodoro, M. G., & Musiani, P. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199812)186:4<390::aid-path194>3.0.co;2-z · Cited by 15
Impact of Tumor‐Derived CCL2 on Macrophage Effector Function
Brault, M. S., & Kurt, R. A. (2005) · BioMed Research International · doi:10.1155/jbb.2005.37 · Cited by 15
Ben‐Baruch, A. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_11 · Cited by 9
Self-citationMoog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2
Cited by
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Liang, Y., Zhang, H., Song, X., & Yang, Q. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.012 · Cited by 992
Roussos, E. T., Condeelis, J. S., & Patsialou, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3078 · Cited by 896
Picon‐Ruiz, M., Morata‐Tarifa, C., Valle‐Goffin, J. J., Friedman, E. R., & Slingerland, J. M. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21405 · Cited by 893
Tumor entrained neutrophils inhibit seeding in the premetastatic lung
Granot, Z., Henke, E., Comen, E. A., King, T. A., Norton, L., & Benezra, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.012 · Cited by 782
Metadata
- Authors
- Soria, G., & Ben-Baruch, A.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 267
- Issue
- 2
- Pages
- 271-285
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2003409252
- Cited by
- 593
- References
- 96
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.